/
AIMD
$1.79+$0.06 (+3.47%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$12.7M
7M shares
52-week range
$1.26 – $4.50
16% from low
Sector
COMPUTER PERIPHERAL EQUIPMENT, NEC
Exchange
NASDAQ
CS
Borrow rate
21.48%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-313.22
Ainos, Inc. Common Stock
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
www.ainos.com- Employees
- 41
- IPO / List date
- Aug 8, 1996
- HQ
- HOUSTON, TX
Held by traders on TradeandTell
No one on the platform currently holds AIMD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 66,300 | $108.7K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-06-30 | 1-for-5reverse |
| 2023-12-14 | 1-for-5reverse |
| 2022-08-09 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded AIMD yet.
